Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

Our News on Newswise
View All >

VIDEO

Q&A with Leaders of MS Virtual 2020 Conference

ACTRIMS MS Virtual 2020 Q&A with Association Leadership
16-Sep-2020 5:10 PM EDT Add to Favorites

VIDEO

Primary astrocytopathy has a detrimental effect on remyelination efficacy of parenchymal oligodendrocyte precursor cells

22-Sep-2020 9:50 AM EDT Add to Favorites

VIDEO

Phase 2 clinical trial evidence that a retinoid-X receptor agonist promotes remyelination in people with relapsing-remitting multiple sclerosis

22-Sep-2020 10:05 AM EDT Add to Favorites

VIDEO

Neutrophil granulocyte markers in cerebrospinal fluid differentiate NMOSD and anti-MOG antibody associated disease from MS in acute disease phase

22-Sep-2020 10:15 AM EDT Add to Favorites

VIDEO

Brain microstructural and metabolic alterations detected in vivo at the onset of the first demyelinating event

22-Sep-2020 10:30 AM EDT Add to Favorites

VIDEO

Network analysis identifies gut bacteria associated with multiple sclerosis relapse among pediatric-onset patients

22-Sep-2020 11:05 AM EDT Add to Favorites

VIDEO

Interrupting disease modifying treatment for pregnancy in multiple sclerosis – effect on disease activity and serum neurofilament light chain

22-Sep-2020 11:15 AM EDT Add to Favorites

VIDEO

COVID-19 in people with MS: A large community-based study of the UK MS Register

22-Sep-2020 11:40 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Abstracts Released for the Cutting Edge Developments Presented at ACTRIMS Forum 2018

Late breaking abstracts
5-Feb-2018 10:05 AM EST

Newswise: Segal_Ben_Pix-NEWusethis_2-17-152.jpg

Benjamin M. Segal, M.D., University of Michigan, Co-Chair of ACTRIMS Forum 2016

11-Nov-2015 4:05 PM EST

Fiona Costello, MD, FRCPC, University of Calgary, is Co-Chair of ACTRIMS Forum 2016

9-Nov-2015 5:05 PM EST

Jack Antel, M.D., McGill University, President-Elect of ACTRIMS

9-Nov-2015 5:05 PM EST

Our YouTube Videos
View All >

About

Founded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS®) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education and collaboration among disciplines. ACTRIMS also provides an annual Forum for experienced and newer clinicians and researchers to exchange information, debate current issues and discuss advances related to basic research and clinical issues. One of the major initiatives of ACTRIMS is to foster the careers of young neurologists in training who have an interest in multiple sclerosis; this is done through a Resident Summit held in conjunction with the annual Forum and a standalone summit geared towards young scientists.